Home › In a twist, Teva to face generic competition
 

Keywords :   


In a twist, Teva to face generic competition

2015-04-17 00:07:31| Biotech - Topix.net

The Food and Drug Administration on Thursday approved the first generic version of Teva's top branded product, the multiple sclerosis drug Copaxone. Teva , based in Israel with its North American headquarters in North Wales, Pa., had spent several years in court battles trying to fend off competition for its MS drug.

Tags: face competition generic twist

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Who is Paula Vennells? Ex-Post Office boss in Horizon IT inquiry
16.05BASF Expands Biomass Balance Portfolio for Selected Chemical Intermediates
16.05INDA Releases 11th Annual North America Supply Report
16.05Dow and SCGC Partner to Change 200KTA of Plastic Waste Into Circular Products
16.05Leanpath Uses Generative AI to Drive Action on Food Waste Data
16.05AkzoNobels Como Site Achieves Highest Automotive Industry Quality Certification
16.05ECONWARDs Counterplan for Landfill-Bound Organics
16.05Mortgage rates cut but borrowing pressures remain
More »